Back to mobile site

Fate Therapeutics (FATE) PT Lowered to $115 at H.C. Wainwright

March 4, 2022 6:17 AM EST Send to a Friend
H.C. Wainwright analyst Debjit Chattopadhyay ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login